Buy & Sell Citius Pharmaceuticals Inc (CTXR) – Citius Pharmaceuticals Inc Price Today
Aura AI Summary
Key Stats
- $18.09MMarket Cap
- HealthSector
- -38.01%3M Drawdown
- $12.20MEnterprise Value
- -Dividend Yield
- 100% Buy | 0% SellTrading Activity
- 5 daysTypical Hold Time
Citius Pharmaceuticals Inc (CTXR) is currently valued at a market capitalization of $18.09M, with an enterprise value of $12.20M. Over the past 52 weeks, Citius Pharmaceuticals Inc has traded between a low of $0.6 and a high of $2.21, highlighting its annual price range. Over the past three months, Citius Pharmaceuticals Inc has recorded a drawdown of -38.01%, reflecting recent price volatility. On average, investors hold Citius Pharmaceuticals Inc for approximately 5 days, indicating typical investor behavior on the platform.
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Most Recent News
US stock futures rise as Trump clears Nvidia chip sales to China amid mixed economic data.
US stock futures gained following a mixed market close and President Trump's approval of Nvidia's H200 AI chip sales to Chinese firms, although China has halted deliveries. Economic data showed a 0.5% rise in April retail sales and a slight increase ...
Verde Resources to attend GenZero Climate Summit in Singapore to expand sustainable infrastructure globally.
Verde Resources Inc. announced its invitation to the GenZero Climate Summit 2026 in Singapore, a key event focused on advancing net zero solutions. The company aims to expand its presence in Singapore and Southeast Asia, leveraging its newly establis...
Boeing stock rises on hints of large aircraft orders from China amid Trump-Xi talks.
Boeing shares rose following Treasury Secretary Scott Bessent's indication of significant aircraft orders from China during President Trump's meeting with Chinese President Xi Jinping. The U.S.-China tariff dispute had previously halted Boeing delive...